R&D

Lund University researchers found the test demonstrated promise in discriminating between persons with and without Alzheimer's disease.

Dexcom CEO says the company has made progress on "several fronts" regarding the G7 pivotal trials, however the company is no longer disclosing timeline specifics.

A team at the University of Colorado (CU) Denver has made a breakthrough in this endeavor using materials called liquid crystal elastomers (LCEs) to create devices that mimic cartilage and other biological tissues.

Researchers from Brigham and Women's Hospital conducted a systematic review and meta-analysis, analyzing data from more than 3,000 specimens to compare COVID-19 detection approaches.

The Wayne, PA-based company announced the results of the Tack Optimized Balloon Angioplasty (TOBA) II BTK clinical trial during the 2020 Vascular Interventional Advances (VIVA) Late-Breaking Clinical Trial livestream.

It’s exciting to start a company with a new medical device. Don’t let that excitement get in the way of planning.

Boston, MA-based Empatica will work with BARDA to validate, Aura, a system with the potential to alert individuals when it detects a likely COVID-19 infection, enabling them to self-isolate and seek early treatment.